中国医药

- 600056

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2020  2019  2018  2017  2016  2015  2014  2013  2012  2011 
中国医药(600056) 利润表
单位:万元
报表日期2020-09-302020-06-302020-03-312019-12-312019-09-30
一、营业总收入3,026,727.481,880,922.61748,511.693,528,482.432,602,558.95
营业收入3,026,727.481,880,922.61748,511.693,528,482.432,602,558.95
二、营业总成本2,831,986.251,760,254.70707,458.863,349,451.832,454,638.86
营业成本2,539,585.131,568,922.79622,424.312,880,947.782,105,306.12
营业税金及附加8,318.015,444.322,178.9611,435.878,658.15
销售费用198,372.39128,324.0456,345.79343,864.76260,083.28
管理费用63,779.9041,453.2118,727.6687,035.0562,443.62
财务费用17,785.0313,109.886,246.1415,414.0012,096.66
研发费用4,145.803,000.451,535.9910,754.376,051.04
资产减值损失----------
公允价值变动收益20.819.733.01136.75--
投资收益5,388.012,132.18200.57-5,311.887.83
其中:对联营企业和合营企业的投资收益6,338.262,481.36427.000.41--
汇兑收益----------
三、营业利润190,429.24119,659.8941,659.46168,938.91156,153.94
加:营业外收入717.16562.44239.851,448.12385.07
减:营业外支出2,345.39612.19436.181,116.43532.27
其中:非流动资产处置损失----------
四、利润总额188,801.01119,610.1441,463.14169,270.60156,006.74
减:所得税费用47,176.0931,401.1010,418.5843,757.5336,906.72
五、净利润141,624.9288,209.0431,044.56125,513.07119,100.03
归属于母公司所有者的净利润123,805.5777,748.2926,402.7598,134.5896,873.09
少数股东损益17,819.3610,460.764,641.8127,378.4922,226.94
六、每股收益
基本每股收益(元/股)1.15870.72760.24710.91840.9066
稀释每股收益(元/股)1.15870.72760.24710.91840.9066
七、其他综合收益-16.39-----994.05--
八、综合收益总额141,608.5388,209.0431,044.56124,519.02119,100.03
归属于母公司所有者的综合收益总额123,789.1777,748.2926,402.7597,138.9396,873.09
归属于少数股东的综合收益总额17,819.3610,460.764,641.8127,380.0922,226.94
下载全部历史数据到excel中 返回页顶